JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312705

Alexa Fluor® 568 Anti-ATE1 抗体 [EPR13667(2)] - N-terminal

Alexa Fluor® 568 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal ATE1 antibody - conjugated to Alexa Fluor® 568.

別名を表示する

Arginyl-tRNA--protein transferase 1, Arginyltransferase 1, R-transferase 1, Arginine-tRNA--protein transferase 1, ATE1

関連する標識済み抗体及び組成の異なる製品 (10)

  • Unconjugated

    Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • 578 PE

    PE Anti-ATE1 antibody [EPR13667(2)] (N-terminal)

  • 660 APC

    APC Anti-ATE1 antibody [EPR13667(2)] (N-terminal)

  • HRP

    HRP Anti-ATE1 antibody [EPR13667(2)] (N-terminal)

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-ATE1 antibody [EPR13667(2)] - N-terminal

  • Carrier free

    Anti-ATE1 antibody [EPR13667(2)] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR13667(2)

アイソタイプ

IgG

標識

Alexa Fluor® 568

励起波長/蛍光波長

Ex: 578nm, Em: 603nm

キャリアフリー

No

アプリケーション

Target Binding Affinity, Antibody Labelling

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle|Store in the dark

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

ATE1 also known as Arginyltransferase 1 is an important enzyme that plays a mechanical role in cellular processes. It is responsible for adding the amino acid arginine to the N-terminus of certain target proteins a modification important for protein stability and function. ATE1 has a molecular mass of approximately 75 kDa. This enzyme is expressed in various tissues with higher expression levels observed in the heart liver and brain indicating its importance in these areas.
Biological function summary

ATE1 acts as a regulator in protein degradation by tagging proteins with arginine marking them for ubiquitination and subsequent proteasomal degradation. This function is critical for controlling the protein turnover and maintaining cellular homeostasis. ATE1 functions independently and is not known to be a part of any larger protein complex emphasizing its specific role in post-translational modification of proteins.

Pathways

This arginylation process by ATE1 integrates into the ubiquitin-proteasome system a pathway significant for protein catabolism. It plays a role in cellular stress responses linking closely with the protein degradation pathways to control damaged or misfolded proteins. ATE1's activity interacts with proteins such as ubiquitin ligases which assist in the tagging and recognition of proteins for degradation ensuring proper proteostasis.

ATE1 has been implicated in cardiac hypertrophy and cancer. Altered expression or activity of ATE1 can contribute to the dysregulation of protein turnover in the heart connecting it to cardiac hypertrophy. In cancer abnormal arginylation can affect cellular homeostasis and lead to uncontrollable cell proliferation. ATE1 connects to proteins like N-end rule substrates in the context of these diseases acting as a potential biomarker or therapeutic target for disease intervention.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Involved in the post-translational conjugation of arginine to the N-terminal aspartate or glutamate of a protein (PubMed : 34893540). This arginylation is required for degradation of the protein via the ubiquitin pathway (PubMed : 34893540). Does not arginylate cysteine residues (By similarity).
See full target information ATE1

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

関連製品

Select an associated product type
Alternative Version
Primary Antibodies

AB232619

Anti-ATE1 antibody [EPR13667(2)] - BSA and Azide free

primary-antibodies

ate1-antibody-epr136672-bsa-and-azide-free-ab232619

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com